AC
CELU icon

Armistice Capital’s Celularity CELU Stock Holding History

Armistice Capital’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-470,000
Closed -$1.04M – 315
2023
Q3 		$1.04M Buy
470,000
+5,700
+1% +$20.5K 0.02% 144
2023
Q2 		$2.47M Buy
+464,300
New +$2.97M 0.04% 141
2022
Q3 		– Sell
-186,813
Closed -$6.35M – 205
2022
Q2 		$6.35M Buy
+186,813
New +$15.2M 0.11% 95

Other funds holding CELU

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
IIA
IPG Investment Advisors San Diego, California $696M AUM 46.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Armistice Capital's CELU Position: Q4 2023 in Review

Armistice Capital sold out of Celularity (CELU) in Q4 2023, closing a stake of 470,000 shares — an estimated $1.04M sold.

Armistice Capital first reported a position in CELU in Q2 2022 and held it in 3 quarters. The position peaked at $6.35M in Q2 2022. 37 funds tracked by Wall St. Rank hold CELU as of Q4 2023.

  • Armistice Capital reported no remaining Celularity position as of Q4 2023 after selling out during the quarter.
  • Armistice Capital sold 470,000 Celularity shares in Q4 2023, an estimated $1.04M.
  • Armistice Capital first reported a position in Celularity in Q2 2022 and held it in 3 quarters.
  • Armistice Capital's Celularity position peaked at $6.35M in Q2 2022.
  • 37 funds tracked by Wall St. Rank held Celularity as of Q4 2023.

Based on Armistice Capital's 13F filing for Q4 2023, filed 13 Feb 2024.